Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Hodgkin Disease 24Lymphoma 18Testicular Neoplasms 4Teratoma 3Recurrence 3Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3HIV Infections 3Vulvar Neoplasms 2Testicular Germ Cell Tumor 2Seminoma 2Neoplasms, Germ Cell and Embryonal 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Head and Neck Neoplasms 2Endodermal Sinus Tumor 2Dendritic Cell Sarcoma, Interdigitating 2Carcinoma, Embryonal 2Burkitt Lymphoma 2Acquired Immunodeficiency Syndrome 2Waldenstrom Macroglobulinemia 1Ulcer 1Squamous Cell Carcinoma of Head and Neck 1Sertoli-Leydig Cell Tumor 1Sarcoma, Kaposi 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Processes 1Ovarian gynandroblastoma 1

Interventions

pembrolizumab 6Cisplatin 5Radiotherapy 4Paclitaxel 3Nivolumab 3lenvatinib 2Specimen Handling 2Platinum 2Papillomavirus Vaccines 2Magnetic Resonance Spectroscopy 2Ipilimumab 2Gemcitabine 2Carboplatin 2CTLA-4 Antigen 2Bleomycin 2Bevacizumab 21,2-diaminocyclohexaneplatinum II citrate 2zimberelimab 1rocakinogene sifuplasmid 1liposomal doxorubicin 1durvalumab 1dostarlimab 1cemiplimab 1belzutifan 1antineoplaston AS 2-1 1antineoplaston A10 1alovudine 1aldesleukin 1Watchful Waiting 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Vulvar Neoplasms × Bleomycin × Clear all
NCT06715592 2025-08-08

ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 2 Active not recruiting
18 enrolled
Gynecologic

Vulvar Neoplasms

NCT05395962 2022-05-27

Elechtra

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase 2 Recruiting
92 enrolled
Gynecologic

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡